Insulin-mediated cortical activity in the slow frequency range is diminished in obese mice and promotes physical inactivity

Diabetologia. 2009 Nov;52(11):2416-2424. doi: 10.1007/s00125-009-1522-5. Epub 2009 Sep 15.

Abstract

Aims/hypothesis: There is evidence from mouse models and humans that alterations in insulin action in the brain are accompanied by an obese phenotype; however, the impact of insulin with regard to behavioural aspects such as locomotion is unknown.

Methods: To address insulin action in the brain with regard to cortical activity in distinct frequency bands and the behavioural consequences, the insulin signalling pathway was followed from the receptor to electrical activity and locomotion. Western blot analysis, electrocorticograms with intracerebroventricular (i.c.v.) application of insulin, and measurements of locomotor activity were performed in lean and obese, as well as Toll-like receptor (TLR) 2/4-deficient, mice.

Results: We show that insulin application i.c.v. into lean mice was accompanied by a profound increase in cortical activity in the slow frequency range, while diet-induced obese mice displayed insulin resistance. In parallel, insulin administered i.c.v. increased locomotor activity in lean mice, whereas a phosphatidylinositol-3 (PI3) kinase inhibitor or obesity abolished insulin-mediated locomotion. A potential candidate that links insulin signalling to locomotion is the Kv1.3 channel that is activated by PI3-kinase. Pharmacological inhibition of Kv1.3 channels that bypassed insulin receptor activation promoted activity. Moreover, mice deficient in TLR2/4-dependent signalling displayed an increase in cortical activity in the slow frequency range that was correlated with improved spontaneous and insulin-mediated locomotor activity.

Conclusions/interpretation: Our data provide functional evidence for a direct effect of insulin on brain activation patterns in the slow frequency bands and locomotor activity in lean mice, while in obese mice, insulin-mediated locomotion is blunted and further aggravates physical inactivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / physiopathology*
  • Cerebral Ventricles / drug effects
  • Cerebral Ventricles / physiopathology
  • Insulin / administration & dosage
  • Insulin / pharmacology*
  • Insulin Resistance / physiology*
  • Lethargy / physiopathology*
  • Locomotion / drug effects
  • Locomotion / physiology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Obese / physiology*
  • Obesity / physiopathology
  • Phosphatidylinositol 3-Kinases / drug effects
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphorylation
  • Receptor, Insulin / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Telemetry / methods
  • Toll-Like Receptor 2 / deficiency
  • Toll-Like Receptor 2 / physiology

Substances

  • Insulin
  • Tlr2 protein, mouse
  • Toll-Like Receptor 2
  • Phosphatidylinositol 3-Kinases
  • Receptor, Insulin